Evidence map›Paper›PMID 40326167›Full record

ArticleCNS neuroscience & therapeutics2025

Regulation of Nrf2/GPX4 Signaling Pathway by Hyperbaric Oxygen Protects Against Depressive Behavior and Cognitive Impairment in a Spinal Cord Injury Rat Model.

Chenlu Li, Zhongyue Wu, Fuxiang Chen, Chaoxian Dai, Xinyi Yang, Shumin Ye, Meng Shi, Peng Chen, Xueyan Liu, Fang Liu

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chenlu LiDepartment of Hyperbaric Oxygen, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.ORCID 0000-0002-9268-9217
Zhongyue WuDepartment of Hyperbaric Oxygen, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Fuxiang ChenDepartment of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Chaoxian DaiFujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.
Xinyi YangDepartment of Hyperbaric Oxygen, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Shumin YeDepartment of Medicinal Chemistry, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
Meng ShiFujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.
Peng ChenDepartment of Sports Medicine, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital of Fujian Medical University, Fujian, China.
Xueyan LiuFujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.ORCID 0000-0002-7229-2810
Fang LiuDepartment of Hyperbaric Oxygen, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.ORCID 0009-0006-8173-5157

Funding

Fujian Provincial Finance Project BPB-CDR2021Fujian Provincial Health Technology Project 2022TG011Science and Technology Innovation Joint Fund Project, Fujian province 2020Y9102
6 · The paper itself

Abstract

aimsNeuroinflammation, microglial activation, and oxidative stress contribute to neuropsychiatric deficits following spinal cord injury (SCI). Hyperbaric oxygen (HBO) therapy has demonstrated anti-inflammatory, antioxidant, and neuroprotective properties. This study aimed to investigate the therapeutic effects and underlying mechanisms of HBO on depressive-like behavior, cognitive impairment, and hippocampal pathology in a rat model of SCI.

methodsWe employed a battery of behavioral assessments, unbiased stereological analysis, immunofluorescence staining, and biochemical assays to evaluate neuroinflammation, oxidative stress, mitochondrial damage, and iron accumulation in the hippocampus. Untargeted proteomic analysis was conducted to identify potential molecular targets of HBO. Western blotting was used to assess the activation of the Nrf2/GPX4 signaling pathway. ML385, a selective Nrf2 inhibitor, was intrathecally administered 30 min prior to daily HBO treatment to validate pathway involvement.

resultsHBO treatment significantly alleviated depressive-like behavior and cognitive deficits in SCI rats. It also suppressed M1-type microglial activation and reduced hippocampal neuroinflammation. Additionally, HBO mitigated neuronal ferroptosis induced by SCI through activation of the Nrf2/GPX4 signaling pathway. The protective effects of HBO were abolished by coadministration of ML385, confirming the critical role of Nrf2 signaling in mediating its anti-ferroptosis effects.

conclusionThese findings highlight ferroptosis as a key pathological mechanism in SCI-induced hippocampal damage and suggest that HBO therapy alleviates depressive-like behavior and cognitive impairment by targeting the Nrf2/GPX4 pathway. This study provides new insights into the therapeutic potential of HBO in managing SCI-related neuropsychiatric dysfunction.

Indexed as

Cognitive DysfunctionDepressionHyperbaric OxygenationNF-E2-Related Factor 2Phospholipid Hydroperoxide Glutathione PeroxidaseSpinal Cord InjuriesAnimalsDisease Models, AnimalHippocampusMaleRatsRats, Sprague-DawleySignal Transductionglutathione peroxidase 4, ratNfe2l2 protein, ratNF-E2-Related Factor 2Phospholipid Hydroperoxide Glutathione Peroxidasecognitive impairmentdepressive behaviorferroptosisGPX4hyperbaric oxygenproteomicsspinal cord injury

Identifiers

PMID40326167
PMCPMC12053091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.